Mucinous cystadenocarcinoma laboratory findings: Difference between revisions
(Created page with "__NOTOC__ {{Mucinous cystadenocarcinoma}} {{CMG}} ==Overview== Blood workup of patients suffering from mucinous cystadenocarcinoma may reveal positivity for various tumor mar...") |
No edit summary |
||
Line 16: | Line 16: | ||
==References== | ==References== | ||
{{ | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 14:58, 19 May 2019
Mucinous cystadenocarcinoma Microchapters |
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mucinous cystadenocarcinoma laboratory findings On the Web |
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma laboratory findings |
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
Risk calculators and risk factors for Mucinous cystadenocarcinoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Blood workup of patients suffering from mucinous cystadenocarcinoma may reveal positivity for various tumor markers such as CA-125, elevated human chorionic gonadotropin (HCG), alpha-fetoprotein, lactate dehydrogenase, inhibin, estrogen and testosterone levels.
Laboratory Findings
Blood workup of patients suffering from mucinous cystadenocarcinoma may reveal positivity for the following tumor markers:
- CA-125
- Elavted human chorionic gonadotropin (HCG)
- Elevated alpha-fetoprotein (AFP)
- Lactate dehydrogenase (LDH)
- Elevated inhibin (hormone)
- Elevated estrogen levels
- Elevated testosterone levels